CERo Therapeutics Holdings Inc

NAS:CERO (USA)  
$ 0.92 -0.0223 (-2.37%) 10:08 PM EST
At Loss
Market Cap:
$ 13.82M
Enterprise V:
$ 21.23M
Volume:
64.44K
Avg Vol (2M):
819.68K
Volume:
64.44K
At Loss
Avg Vol (2M):
819.68K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for CERO ( CERo Therapeutics Holdings Inc ) from 2024 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CERo Therapeutics stock (CERO) PE ratio as of May 26 2024 is 0. More Details

CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Chart

To

CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Historical Data

Total 71
  • 1
CERo Therapeutics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-27 At Loss 2024-04-08 At Loss
2024-05-24 At Loss 2024-04-05 At Loss
2024-05-23 At Loss 2024-04-04 At Loss
2024-05-22 At Loss 2024-04-03 At Loss
2024-05-21 At Loss 2024-04-02 At Loss
2024-05-20 At Loss 2024-04-01 At Loss
2024-05-17 At Loss 2024-03-28 At Loss
2024-05-16 At Loss 2024-03-27 At Loss
2024-05-15 At Loss 2024-03-26 At Loss
2024-05-14 At Loss 2024-03-25 At Loss
2024-05-13 At Loss 2024-03-22 At Loss
2024-05-10 At Loss 2024-03-21 At Loss
2024-05-09 At Loss 2024-03-20 At Loss
2024-05-08 At Loss 2024-03-19 At Loss
2024-05-07 At Loss 2024-03-18 At Loss
2024-05-06 At Loss 2024-03-15 At Loss
2024-05-03 At Loss 2024-03-14 At Loss
2024-05-02 At Loss 2024-03-13 At Loss
2024-05-01 At Loss 2024-03-12 At Loss
2024-04-30 At Loss 2024-03-11 At Loss
2024-04-29 At Loss 2024-03-08 At Loss
2024-04-26 At Loss 2024-03-07 At Loss
2024-04-25 At Loss 2024-03-06 At Loss
2024-04-24 At Loss 2024-03-05 At Loss
2024-04-23 At Loss 2024-03-04 At Loss
2024-04-22 At Loss 2024-03-01 At Loss
2024-04-19 At Loss 2024-02-29 At Loss
2024-04-18 At Loss 2024-02-28 At Loss
2024-04-17 At Loss 2024-02-27 At Loss
2024-04-16 At Loss 2024-02-26 At Loss
2024-04-15 At Loss 2024-02-23 At Loss
2024-04-12 At Loss 2024-02-22 At Loss
2024-04-11 At Loss 2024-02-21 At Loss
2024-04-10 At Loss 2024-02-20 At Loss
2024-04-09 At Loss 2024-02-16 At Loss

CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

CERo Therapeutics Holdings Inc
NAICS : 541713 SIC : 2833
ISIN : US71902K1051
Compare
Compare
Traded in other countries / regions
CERO.USA
IPO Date
2024-02-15
Description
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.